Fundraising FoxSeroba Life Sciences — Full Portfolio
35 tracked investments · listed companies and verified rows first
Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.
HealthtechMedical DevicesGalway, IE
Brendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)
Co-investorsJohnson & Johnson Innovation – JJDCEnterprise IrelandLaunch Capital
Palliare develops medical devices for minimally invasive gastrointestinal procedures, including laparoscopy and endoscopy solutions.
HardwareHealthtechMedical DevicesOceanside, IE
John O'Dea(CEO)in
Co-investorsWestern Development Commission
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalV-Bio VenturesVertis SGRVI PartnersClaris Ventures+1 more
Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.
BiotechHealthtechLongevityPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)
Co-investorsAndera PartnersAvego BioScience CapitalGlobal BioAccess FundJeito CapitalNew Rhein Healthcare Investors, LLCAgent Capital+2 more
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsBioGeneration VenturesThuja CapitalBGV
Caldera Medical develops surgical solutions for women's health conditions including stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids.
FemTechHealthtechMedical Devices
Co-investorsAndera PartnersBorski FundAtlantic Bridge VenturesEarlybird Venture CapitalEQT Life Sciences
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.
BiotechDeep TechHealthtechMedical DevicesLeiden, NL
Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)
Co-investorsBioGeneration VenturesBioMedPartnersForbionJeito CapitalPictet GroupAsahi Kasei Corporate Venture Capital
Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Co-investorsFund+Kurma PartnersV-Bio VenturesBpifranceGO CapitalInvus+2 more
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsBioGeneration VenturesCambridge Innovation CapitalGimvHadean VenturesBGVForbion+2 more
Deciphex develops AI-powered platforms to enhance pathology efficiency, including digital image analysis, clinical trial support, and a global network of subspecialty pathologists.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsAct Venture CapitalACT Venture CapitalClaret Capital PartnersMolten Ventures
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)inAnthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Co-investorsAPERTURE Venture PartnersBioventures InvestorsJumpstart VenturesLumira VenturesOSF VenturesSV Health Investors+1 more
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
John Valliant(Founder)in
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesPivotal Life SciencesVenture OntarioYsios Capital+6 more
Labcyte developed acoustic droplet ejection ("Echo") liquid-handling instruments that use focused sound waves to transfer nanoliter-scale liquid volumes between microplates without physical contact.
BiotechSunnyvale, US
Richard Ellson(Executive Officer, Director)Tammy Cameron(Executive Officer)Mark Fischer-Colbrie(Executive Officer, Director)
BoardJoseph Smith(Director)Sandra Panem(Director)Joe Keegan(Director)
Co-investorsDBL PartnersGE VenturesJP Morgan Chase
Seroba Ventures is an investment firm focused on bringing breakthrough healthcare solutions to market and addressing unmet patient needs in the global healthcare environment.
BiotechHealthtechMedical Devices
Jeanne Bolger(Venture Partner)
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)inLiam Mullins(CTO and Co-founder)in
Co-investorsSV Health InvestorsEnterprise IrelandEQT Life Sciences
PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health.
BiotechConsumerHealthtechWellness & Fitness
Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.
BiotechHealthtechMedical DevicesCopenhagen, DK
Co-investorsCardinal PartnersM VenturesSunstone CapitalYsios CapitalForbion
Quanta develops the Quanta Dialysis System, a compact, modular hemodialysis machine designed for flexible kidney care in acute and chronic facilities.
HardwareHealthtechMedical DevicesBurbank, US
ERIC RICE(Executive Officer)JEFFREY DOIRON(Executive Officer)BLAKE GILETTE(Executive Officer)KIRK WESTWOOD(Executive Officer)
Co-investorsSeventure PartnersAccelComma Capital
Ryme Medical develops a catheter-based therapy to treat chronic obstructive pulmonary disease (COPD) by reducing airway inflammation and improving patient outcomes.
BiotechHealthtechMedical DevicesMountain View, US
Co-investorsEpidarex Capital
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more
Shorla Oncology develops pharmaceutical products to address unmet needs in oncology.
BiotechHealthtechMedical DevicesDublin, IE
Sharon Cunningham(CEO & Co-Founder)inOrlaith Ryan(CTO & Co-Founder)in
Co-investorsKurma PartnersEnterprise Ireland
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Co-investorsCambridge Innovation CapitalFast Track InitiativeM VenturesPfizer Venture InvestmentsTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.+3 more
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Luc Dochez(Chair and Founder)inJosh Mandel-Brehm(Co-Founder)in
Co-investorsDroia VenturesKurma PartnersPureos BioventuresEQT Life SciencesEurazeoIdinvest Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Agi TherapeuticsApica CardiovascularCovagen AGHeart MetabolicsINNOVO by Atlantic TherapeuticsMedLumicsNovateNovate MedicalPQ BypassShorla PharmaXention
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.